The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collection in Flagship Stores

20 Jul 2005 07:01

Marchpole Holdings PLC20 July 2005 FOR IMMEDIATE RELEASE 20 JULY 2005 Marchpole Holdings PLC ("Marchpole" or the "Company") Launch of Emanuel Ungaro Menswear collections into Flagship Stores Marchpole Holdings plc, the brand management company, today announces that thedebut Emanuel Ungaro menswear collection will be launched into three Ungaroflagship stores. The first two in New Bond Street, London and Avenue Montaigne,Paris, will be in time for this coming Autum Winter 2005 season and the third,in Madison Avenue, New York, for Spring Summer 2006. The menswear collection, licensed by Marchpole and designed by Creative DirectorJose Levy, will occupy 300 sq ft of the existing New Bond Street store and 450sq ft within Avenue Montaigne. At both locations the menswear will be apermanent feature in two of the store's windows. The first collection, AutumnWinter 2005, will be available from August. The Madison Avenue store, New Yorkwill occupy 595 sq ft, with two permanent windows on 67th Street and a window onMadison Avenue The debut collection comprises of two entities, Emanuel Ungaro (formal wear) andUngaro (casual wear). For Autumn Winter, Emanuel Ungaro focuses on tailoringwith suits, jackets, shirts and fine knits including an evening dress collectionentitled 'Le Soir' which features shirts produced by the fashion houses atelierin Paris. Ungaro, in contrast, offers a more casual look with t-shirts, knitsand denim. The collections share distinctive characteristics of slim elegantsilhouettes, seam movement on jackets, shirts, t-shirts and knits and recurringpolka dot and floral patterns all inspired by the couture heritage of thefashion house. The decision to launch the collection through the existing Ungaro flagship storedemonstrates Marchpole's commitment to keep the collections launch true to thelabel values and heritage. The design team will be working alongside theateliers, illustrating the Parisian fashion house's support of the menswearcollection and license. Greg Tufnell, CEO of Marchpole, commented: 'We are delighted to be working so closely with the House of Ungaro, and theirstores will provide a powerful platform for the brand as we expand the businessto an International audience.' For further information please contact: Marchpole: 020 7908 7700Greg Tufnell, Chief ExecutiveJustin Hampshire, Finance DirectorMichael Morris, Executive Director Yellowdoor: 020 7580 0707Caireen Wackettcaireenwackett@yellow-door.co.uk Buchanan Communications: 020 7466 5000Nicola Cronk Notes to editors Marchpole Marchpole hold the license to design and distribute Emanuel Ungaro and Ungaromenswear worldwide, with the exception of the US, until 2012. The brandmanagement company, renowned for design, production and sales of high qualityclothing and accessories, currently holds six world class brands in itsportfolio including Yves Saint Laurent pour homme, Boateng and Jean Charles deCastelbajac. In May this year, Marchpole announced its preliminary results for the year ended31 March 2005, with turnover up 62% at £32.5 million and profit before tax up79% at £4.7 million. For further information, please go to www.marchpole.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Dec 20206:22 pmRNSAIM Delisting
30th Nov 20207:00 amRNSKey Dates for AIM Delisting
23rd Nov 202012:00 pmRNSMereo appoints Suba Krishnan
16th Nov 202012:00 pmRNSVirtual R&D Day
11th Nov 20207:00 amRNSCancellation of AIM admission
10th Nov 202012:00 pmRNSStifel 2020 Virtual Healthcare Conference
20th Oct 202012:00 pmRNSAppointments of CFO and SVP
19th Oct 202012:00 pmRNSTIGIT IND FDA Clearance
12th Oct 20201:44 pmRNSPDMR Notification
9th Oct 20204:05 pmRNSDirector/PDMR Shareholding
7th Oct 202012:00 pmRNSRegistration Statement Filed with US SEC
29th Sep 202012:00 pmRNSInterim Results for 6 months ended June 30, 2020
28th Sep 20203:21 pmRNSResult of General Meeting
28th Sep 202012:00 pmRNSChanges to Board of Directors
24th Sep 202012:00 pmRNSFDA Rare Pediatric Disease Designation
16th Sep 20201:00 pmRNSNotice of Interim Results
4th Sep 20207:00 amRNSNotice of General Meeting
25th Aug 202012:00 pmRNSInitiation of COVID-19 Respiratory Disease Trial
14th Aug 20207:00 amRNSPDMR Notification
13th Aug 20207:00 amRNSNotification of PDMR Dealing
6th Aug 20207:00 amRNSAppointment of Nominated Adviser & Broker
5th Aug 20207:00 amRNSDirector Dealing
6th Jul 20203:59 pmRNSHolding(s) in Company
6th Jul 20209:34 amRNSBlock Listing Application
30th Jun 20201:39 pmRNSResult of General Meeting
30th Jun 202012:00 pmRNSCSO and SVP appointments
29th Jun 20203:56 pmRNSResult of Annual General Meeting
22nd Jun 20204:33 pmRNSHolding(s) in Company
22nd Jun 202011:06 amRNSSecond Price Monitoring Extn
22nd Jun 202011:00 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSFinal Results for the year ended December 31, 2019
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20205:30 pmRNSHolding(s) in Company
9th Jun 20204:45 pmRNSNotice of General Meeting
8th Jun 20205:56 pmRNSHolding(s) in Company
8th Jun 20205:18 pmRNSHolding(s) in Company
8th Jun 20203:20 pmRNSHolding(s) in Company
5th Jun 20203:55 pmRNSHolding(s) in Company
5th Jun 202012:49 pmRNSHolding(s) in Company
4th Jun 20202:05 pmRNSSecond Price Monitoring Extn
4th Jun 20202:00 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSCompletion of $70 Million Private Placement
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
27th May 202012:00 pmRNSNotice of Annual General Meeting
22nd May 202012:00 pmRNSAnnual General Meeting
21st May 20204:18 pmRNSHolding(s) in Company
27th Mar 202012:00 pmRNSBusiness Update and Directorate Change
6th Mar 20207:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.